MiR-665 inhibits inflammatory response in microglia following spinal cord injury by targeting TREM2

S Liu1, X-M Li, J-B Yuan

  • 1Department of Orthopaedics, Changhai Hospital, Second Military Medical University, Shanghai, China. zhicaishi@vip.sina.com.

Abstract

Insights

MicroRNA-665 (miR-665) protects against inflammation after spinal cord injury (SCI) by targeting TREM2. This study reveals miR-665

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Immunology

Background:

  • Spinal cord injury (SCI) triggers significant inflammatory responses in microglia.
  • MicroRNAs play crucial roles in regulating cellular processes, including inflammation.
  • Understanding the molecular mechanisms underlying SCI-induced inflammation is vital for developing therapeutic strategies.

Purpose of the Study:

  • To investigate the role of microRNA-665 (miR-665) in mitigating microglial inflammatory responses post-SCI.
  • To elucidate the underlying molecular mechanism involving miR-665 and its target gene, TREM2.

Main Methods:

  • Quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) and Enzyme-Linked Immunosorbent Assay (ELISA) were used to measure miR-665, TREM2, IL-6, and TNF-α levels in patient serum and cell cultures.
  • Dual-Luciferase reporter assay was employed to confirm TREM2 as a direct target of miR-665.
  • In vitro experiments involved lipopolysaccharide (LPS) induction in BV2 microglial cells to mimic SCI conditions.

Main Results:

  • miR-665 levels were found to be downregulated in SCI patients and LPS-induced BV2 cells, while TREM2 expression was upregulated.
  • Silencing miR-665 or overexpressing TREM2 exacerbated the inflammatory response.
  • Rescue experiments confirmed that miR-665 regulates inflammatory responses in SCI by targeting TREM2.

Conclusions:

  • MicroRNA-665 plays a protective role in the inflammatory response following spinal cord injury.
  • The mechanism involves miR-665 targeting and downregulating the expression of TREM2.
  • Targeting the miR-665/TREM2 axis presents a potential therapeutic avenue for SCI.

Related Concept Videos